X0609 4 2026-05-28 false 0002044725 Evommune, Inc. EVMN 0001757072 Carver Kyle false C/O EVOMMUNE, INC. 1891 PAGE MILL ROAD PALO ALTO CA 94304 false true false false Chief Financial Officer true Common Stock 2026-05-28 4 M false 15000.00 2.99 A 77510.00 D Common Stock 2026-05-28 4 S false 18175.00 22.84 D 59335.00 D Employee Stock Option (Right to Buy) 2.99 2026-05-28 4 M false 15000.00 0.00 D 2034-12-08 Common Stock 15000.00 96731.00 D The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 26, 2026. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $22.50 to $23.42 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. One fourth (1/4) of the shares subject to the option award shall vest on the first anniversary of the grant date and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. /s/ Gregory S. Moss, Attorney-in-Fact 2026-06-01